Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
JYOTHYLAB.NS Stock Summary
Top 10 Correlated ETFs
JYOTHYLAB.NS
In the News
JYOTHYLAB.NS Financial details
Company Rating
Neutral
Market Cap
159.74B
Income
3.51B
Revenue
27.14B
Book val./share
-
Cash/share
-
Dividend
3
Dividend %
0.61%
Employees
2.6K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
55.41
Forward P/E
-
PEG
4.75
P/S
6.85
P/B
11.06
P/C
-
P/FCF
-
Quick Ratio
1.34
Current Ratio
2.04
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
9.55
EPS next Y
-
EPS next Q
-
EPS this Y
48.07%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.05%
Revenue last 5Y
6.52%
Revenue Q/Q
-7.49%
EPS Q/Q
-12.68%
-
-
-
-
SMA20
2.38%
SMA50
-17.31%
SMA100
-3.15%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
41%
ROC
0.25%
Gross Margin
47%
Oper. Margin
16%
Profit Margin
12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
190.45-554.0
52W High
-25.97%
52W Low
+115.87%
RSI
38
Rel Volume
0.15
Avg Volume
1.18M
Volume
174.75K
Perf Week
-7.76%
Perf Month
-8.67%
Perf Quarter
17.42%
Perf Half Y
9.07%
-
-
-
-
Beta
0.585
-
-
Volatility
12.44%, 12.73%
Prev Close
-1.05%
Price
410.15
Change
-1.3%
JYOTHYLAB.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 49.66 | 46.56 | 51.96 | 59.78 | 67.7 | |
Net income per share | 5.62 | 4.64 | 5.43 | 4.41 | 6.53 | |
Operating cash flow per share | 8.26 | 4.67 | 10.95 | 5.52 | 8.95 | |
Free cash flow per share | 7.17 | 3.53 | 10.25 | 4.81 | 7.98 | |
Cash per share | 4.91 | 0.57 | 5.09 | 5.57 | 7.78 | |
Book value per share | 36.35 | 33.46 | 38.9 | 39.31 | 42.18 | |
Tangible book value per share | 14.04 | 11.09 | 16.33 | 16.68 | 20.66 | |
Share holders equity per share | 36.35 | 33.46 | 38.9 | 39.31 | 42.18 | |
Interest debt per share | 8.6 | 10.03 | 5.05 | 4.98 | 1.62 | |
Market cap | 67.11B | 33.86B | 50.23B | 54.14B | 69.95B | |
Enterprise value | 69.16B | 37.06B | 51.18B | 55.1B | 69.36B | |
P/E ratio | 32.72 | 19.88 | 25.19 | 33.43 | 29.18 | |
Price to sales ratio | 3.7 | 1.98 | 2.63 | 2.47 | 2.81 | |
POCF ratio | 22.25 | 19.74 | 12.49 | 26.73 | 21.29 | |
PFCF ratio | 25.65 | 26.15 | 13.35 | 30.68 | 23.87 | |
P/B Ratio | 5.06 | 2.76 | 3.52 | 3.75 | 4.52 | |
PTB ratio | 5.06 | 2.76 | 3.52 | 3.75 | 4.52 | |
EV to sales | 3.82 | 2.17 | 2.68 | 2.51 | 2.79 | |
Enterprise value over EBITDA | 22.53 | 13.74 | 15.36 | 20.75 | 19.52 | |
EV to operating cash flow | 22.93 | 21.61 | 12.73 | 27.2 | 21.11 | |
EV to free cash flow | 26.43 | 28.63 | 13.6 | 31.22 | 23.66 | |
Earnings yield | 0.03 | 0.05 | 0.04 | 0.03 | 0.03 | |
Free cash flow yield | 0.04 | 0.04 | 0.07 | 0.03 | 0.04 | |
Debt to equity | 0.21 | 0.27 | 0.12 | 0.12 | 0.03 | |
Debt to assets | 0.14 | 0.18 | 0.09 | 0.08 | 0.02 | |
Net debt to EBITDA | 0.67 | 1.19 | 0.28 | 0.36 | -0.17 | |
Current ratio | 1.05 | 0.82 | 1.32 | 1.39 | 1.91 | |
Interest coverage | 7.25 | 6.6 | 14.57 | 17.62 | 23.32 | |
Income quality | 1.24 | 0.94 | 1.71 | 1.03 | 1.1 | |
Dividend Yield | 0 | 0.07 | 0 | 0.03 | 0.01 | |
Payout ratio | 0.09 | 1.29 | 0 | 0.91 | 0.38 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.41 | 0.43 | 0.4 | 0.39 | 0.38 | |
Capex to operating cash flow | -0.13 | -0.24 | -0.06 | -0.13 | -0.11 | |
Capex to revenue | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -1.31 | -0.79 | -0.47 | -0.45 | -0.71 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 67.8 | 59.1 | 68.95 | 62.46 | 78.72 | |
ROIC | 0.13 | 0.12 | 0.14 | 0.1 | 0.15 | |
Return on tangible assets | 0.18 | 0.16 | 0.17 | 0.13 | 0.19 | |
Graham Net | -5.72 | -11.12 | -4.37 | -3.94 | 0.92 | |
Working capital | 268.72M | -958.96M | 1.52B | 2.03B | 3.69B | |
Tangible asset value | 5.13B | 4.07B | 6B | 6.13B | 7.59B | |
Net current asset value | -154.02M | -1.88B | 595.09M | 1.04B | 2.64B | |
Invested capital | 0.21 | 0.27 | 0.12 | 0.12 | 0.03 | |
Average receivables | 2.32B | 1.62B | 1.16B | 1.34B | 1.53B | |
Average payables | 1.76B | 1.55B | 1.62B | 2.14B | 2.25B | |
Average inventory | 1.95B | 2.14B | 2.52B | 2.88B | 3B | |
Days sales outstanding | 39.76 | 26.99 | 20.12 | 27.09 | 21.05 | |
Days payables outstanding | 66.86 | 52.55 | 68.89 | 66.81 | 54.53 | |
Days of inventory on hand | 75.56 | 90.4 | 99.82 | 83.94 | 76.79 | |
Receivables turnover | 9.18 | 13.52 | 18.14 | 13.47 | 17.34 | |
Payables turnover | 5.46 | 6.95 | 5.3 | 5.46 | 6.69 | |
Inventory turnover | 4.83 | 4.04 | 3.66 | 4.35 | 4.75 | |
ROE | 0.15 | 0.14 | 0.14 | 0.11 | 0.15 | |
Capex per share | -1.09 | -1.14 | -0.71 | -0.71 | -0.97 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 16.68 | 16.8 | 18.71 | 19.94 | 18.45 | |
Net income per share | 1.84 | 1.61 | 2.62 | 2.84 | 2.48 | |
Operating cash flow per share | 0.66 | 0.65 | 0.65 | 0.67 | 0.7 | |
Free cash flow per share | 0.66 | 0.65 | 0.65 | 0.67 | 0.7 | |
Cash per share | 4.44 | 7.78 | 7.65 | 12.21 | 0 | |
Book value per share | 39.94 | 42.18 | 42.24 | 44.64 | 0 | |
Tangible book value per share | 0 | 20.66 | 0 | 23.13 | 0 | |
Share holders equity per share | 39.94 | 42.18 | 42.24 | 44.64 | 0 | |
Interest debt per share | 0.09 | 1.35 | 0.03 | 1.25 | 0.03 | |
Market cap | 75.22B | 69.95B | 79.26B | 132.38B | 177.2B | |
Enterprise value | 76.85B | 69.36B | 82.07B | 132.22B | 177.2B | |
P/E ratio | 27.91 | 29.52 | 20.58 | 31.78 | 48.74 | |
Price to sales ratio | 12.28 | 11.34 | 11.54 | 18.08 | 26.15 | |
POCF ratio | 309.3 | 293.92 | 331.36 | 537.69 | 690.56 | |
PFCF ratio | 309.3 | 293.92 | 331.36 | 537.69 | 690.56 | |
P/B Ratio | 5.13 | 4.52 | 5.11 | 8.08 | 0 | |
PTB ratio | 5.13 | 4.52 | 5.11 | 8.08 | 0 | |
EV to sales | 12.54 | 11.24 | 11.94 | 18.05 | 26.15 | |
Enterprise value over EBITDA | 77.14 | 71.54 | 61.08 | 88.98 | 137.13 | |
EV to operating cash flow | 316 | 291.44 | 343.11 | 537.05 | 690.56 | |
EV to free cash flow | 316 | 291.44 | 343.11 | 537.05 | 690.56 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.03 | 0 | 0.03 | 0 | |
Debt to assets | 0 | 0.02 | 0 | 0.02 | 0 | |
Net debt to EBITDA | 1.64 | -0.61 | 2.09 | -0.11 | 0 | |
Current ratio | 0 | 1.91 | 0 | 2.04 | 0 | |
Interest coverage | 27.25 | 27.26 | 110.27 | 116.49 | 97.81 | |
Income quality | 0.36 | 0.4 | 0.25 | 0.24 | 0.28 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.38 | 0 | 0.36 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 40.61 | 39.13 | 49.92 | 53.37 | 0 | |
ROIC | 0.05 | 0.04 | 0.06 | 0.06 | 0 | |
Return on tangible assets | 0 | 0.05 | 0 | 0.07 | 0 | |
Graham Net | 4.44 | 0.92 | 7.65 | 4.06 | 0 | |
Working capital | 1.63B | 3.69B | 2.81B | 4.86B | 0 | |
Tangible asset value | 0 | 7.59B | 0 | 8.49B | 0 | |
Net current asset value | 1.63B | 2.64B | 2.81B | 3.77B | 0 | |
Invested capital | 0 | 0.03 | 0 | 0.03 | 0 | |
Average receivables | 949.85M | 716.9M | 716.9M | 905.7M | 905.7M | |
Average payables | 1.24B | 1.07B | 1.07B | 1.26B | 1.26B | |
Average inventory | 1.78B | 1.51B | 1.51B | 1.43B | 1.43B | |
Days sales outstanding | 0 | 20.92 | 0 | 22.26 | 0 | |
Days payables outstanding | 0 | 57.61 | 0 | 61.14 | 0 | |
Days of inventory on hand | 0 | 81.13 | 0 | 69.24 | 0 | |
Receivables turnover | 0 | 4.3 | 0 | 4.04 | 0 | |
Payables turnover | 0 | 1.56 | 0 | 1.47 | 0 | |
Inventory turnover | 0 | 1.11 | 0 | 1.3 | 0 | |
ROE | 0.05 | 0.04 | 0.06 | 0.06 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
JYOTHYLAB.NS Frequently Asked Questions
What is Jyothy Labs Limited stock symbol ?
Jyothy Labs Limited is a IN stock and trading under the symbol JYOTHYLAB.NS
What is Jyothy Labs Limited stock quote today ?
Jyothy Labs Limited stock price is $410.15 today.
Is Jyothy Labs Limited stock public?
Yes, Jyothy Labs Limited is a publicly traded company.